Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs TORRENT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA TORRENT PHARMA AUROBINDO PHARMA/
TORRENT PHARMA
 
P/E (TTM) x 23.0 58.9 39.0% View Chart
P/BV x 2.4 14.2 16.7% View Chart
Dividend Yield % 0.3 0.8 32.6%  

Financials

 AUROBINDO PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
TORRENT PHARMA
Mar-23
AUROBINDO PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs7151,723 41.5%   
Low Rs3971,243 32.0%   
Sales per share (Unadj.) Rs424.2284.2 149.2%  
Earnings per share (Unadj.) Rs32.936.8 89.4%  
Cash flow per share (Unadj.) Rs54.157.7 93.9%  
Dividends per share (Unadj.) Rs3.0022.00 13.6%  
Avg Dividend yield %0.51.5 36.4%  
Book value per share (Unadj.) Rs458.1183.1 250.1%  
Shares outstanding (eoy) m585.94338.45 173.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.35.2 25.1%   
Avg P/E ratio x16.940.3 41.9%  
P/CF ratio (eoy) x10.325.7 39.9%  
Price / Book Value ratio x1.28.1 15.0%  
Dividend payout %9.159.8 15.3%   
Avg Mkt Cap Rs m325,753501,779 64.9%   
No. of employees `000NANA-   
Total wages/salary Rs m35,22316,777 209.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,55496,202 258.4%  
Other income Rs m2,906632 459.6%   
Total revenues Rs m251,46096,834 259.7%   
Gross profit Rs m37,07028,240 131.3%  
Depreciation Rs m12,4467,066 176.1%   
Interest Rs m1,4053,334 42.1%   
Profit before tax Rs m26,12518,472 141.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,8496,019 113.8%   
Profit after tax Rs m19,27712,452 154.8%  
Gross profit margin %14.929.4 50.8%  
Effective tax rate %26.232.6 80.4%   
Net profit margin %7.812.9 59.9%  
BALANCE SHEET DATA
Current assets Rs m214,59953,137 403.9%   
Current liabilities Rs m114,93854,473 211.0%   
Net working cap to sales %40.1-1.4 -2,887.7%  
Current ratio x1.91.0 191.4%  
Inventory Days Days2115 133.1%  
Debtors Days Days667 889.3%  
Net fixed assets Rs m176,66891,390 193.3%   
Share capital Rs m5861,692 34.6%   
"Free" reserves Rs m267,81360,288 444.2%   
Net worth Rs m268,39961,981 433.0%   
Long term debt Rs m6,19024,962 24.8%   
Total assets Rs m392,125144,682 271.0%  
Interest coverage x19.66.5 299.7%   
Debt to equity ratio x00.4 5.7%  
Sales to assets ratio x0.60.7 95.3%   
Return on assets %5.310.9 48.3%  
Return on equity %7.220.1 35.7%  
Return on capital %10.025.1 40.0%  
Exports to sales %33.721.8 154.3%   
Imports to sales %15.30-   
Exports (fob) Rs m83,70320,994 398.7%   
Imports (cif) Rs m38,060NA-   
Fx inflow Rs m85,48320,994 407.2%   
Fx outflow Rs m41,4473,735 1,109.6%   
Net fx Rs m44,03617,259 255.1%   
CASH FLOW
From Operations Rs m23,86823,681 100.8%  
From Investments Rs m-39,778-24,153 164.7%  
From Financial Activity Rs m18,144774 2,345.4%  
Net Cashflow Rs m2,2981,101 208.6%  

Share Holding

Indian Promoters % 48.8 71.3 68.4%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 41.3 21.3 194.0%  
FIIs % 20.7 14.1 147.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 28.8 167.5%  
Shareholders   241,944 69,117 350.0%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs Torrent Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Torrent Pharma Share Price Performance

Period Aurobindo Pharma Torrent Pharma S&P BSE HEALTHCARE
1-Day 1.82% 1.45% 1.18%
1-Month 5.96% -0.30% -0.75%
1-Year 113.07% 68.52% 61.82%
3-Year CAGR 7.78% 27.16% 18.16%
5-Year CAGR 7.18% 21.87% 19.79%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Torrent Pharma share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Torrent Pharma the stake stands at 71.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Torrent Pharma.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

Torrent Pharma paid Rs 22.0, and its dividend payout ratio stood at 59.8%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Torrent Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.